Chronic Lymphocytic Leukemia — Proceedings from a Symposium Held in Partnership with the American Oncology Network
Hematologic Oncology Update
00:00
Xanabrutinib combinations and MRD‑guided stopping
She discusses Sequoia arms, complex MRD stopping rules, and limited treatment cessation in current trials.
Play episode from 07:48
Transcript
